Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma.

Cancer research communications·2026
Same author

"Recurrent Extinction of Resistance Mutations Leads to Convergent Multidrug Resistance in Sequential Antibiotic Treatment".

bioRxiv : the preprint server for biology·2026
Same author

Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma.

NPJ precision oncology·2026
Same author

Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001.

Cancers·2026
Same author

RNA Quality Control Enables Antibiotic Tolerance.

bioRxiv : the preprint server for biology·2026
Same author

Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy.

Journal for immunotherapy of cancer·2025

Related Experiment Video

Updated: Apr 14, 2026

Competitive Genomic Screens of Barcoded Yeast Libraries
11:59

Competitive Genomic Screens of Barcoded Yeast Libraries

Published on: August 11, 2011

18.9K

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat.

Caleb K Stein1, Pingping Qu2, Joshua Epstein3

  • 1Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. CKStein@uams.edu.

BMC Bioinformatics
|April 19, 2015
PubMed
Summary

A new method, M-ComBat, improves gene expression data analysis by adjusting for batch effects. This modification helps maintain the accuracy of predictive models on future samples, enhancing risk assessment in clinical settings.

More Related Videos

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.6K
Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
10:23

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations

Published on: January 19, 2017

11.6K

Related Experiment Videos

Last Updated: Apr 14, 2026

Competitive Genomic Screens of Barcoded Yeast Libraries
11:59

Competitive Genomic Screens of Barcoded Yeast Libraries

Published on: August 11, 2011

18.9K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.6K
Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
10:23

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations

Published on: January 19, 2017

11.6K

Area of Science:

  • Genomics and Bioinformatics
  • Computational Biology
  • Biostatistics

Background:

  • Gene expression profiling (GEP) using microarray analysis is crucial for clinical risk assessment and diagnostics.
  • Batch effects from sample preparation and scanners introduce systematic variability, complicating long-term studies and meta-analyses.
  • ComBat is an existing method to mitigate batch effects in microarray data.

Purpose of the Study:

  • To introduce M-ComBat, a modified ComBat algorithm for gene expression data.
  • M-ComBat centers data to the location and scale of a pre-determined 'gold-standard' batch.
  • To enhance the performance of predictive models in meta-analysis by adjusting for batch effects.

Main Methods:

  • Applied ComBat and M-ComBat to combined microarray datasets with known batch variations.
  • Utilized external datasets from HOVON-65/GMMG-HD4 and MRC-IX trials.
  • Compared fixed and validated gene risk signatures developed on a 'gold-standard' batch.

Main Results:

  • Both ComBat and M-ComBat successfully eliminated systematic batch effects across all probes.
  • M-ComBat demonstrated superior agreement with the 'gold-standard' batch in terms of risk score distribution and high-risk subject identification.
  • M-ComBat improved the performance of risk scores, enabling more precise identification of high-risk cohorts.

Conclusions:

  • M-ComBat is a practical enhancement to ComBat, offering improved control over data location and scale after batch effect adjustment.
  • This method ensures historical predictive models remain effective on future gene expression data despite systematic changes.
  • M-ComBat facilitates more reliable and powerful batch-effect adjusted data analysis for meta-analysis and clinical applications.